PL444224A1 - Sól potasowa nimesulidu oraz sposób otrzymywania kryształów soli potasowych nimesulidu - Google Patents

Sól potasowa nimesulidu oraz sposób otrzymywania kryształów soli potasowych nimesulidu

Info

Publication number
PL444224A1
PL444224A1 PL444224A PL44422423A PL444224A1 PL 444224 A1 PL444224 A1 PL 444224A1 PL 444224 A PL444224 A PL 444224A PL 44422423 A PL44422423 A PL 44422423A PL 444224 A1 PL444224 A1 PL 444224A1
Authority
PL
Poland
Prior art keywords
sub
nimesulide
potassium salt
obtaining
formula
Prior art date
Application number
PL444224A
Other languages
English (en)
Other versions
PL249273B1 (pl
Inventor
Artur Sikorski
Małgorzata Rybczyńska
Original Assignee
Uniwersytet Gdański
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Gdański filed Critical Uniwersytet Gdański
Priority to PL444224A priority Critical patent/PL249273B1/pl
Priority to EP23169129.6A priority patent/EP4438593A1/en
Publication of PL444224A1 publication Critical patent/PL444224A1/pl
Publication of PL249273B1 publication Critical patent/PL249273B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42—Separation; Purification; Stabilisation; Use of additives
    • C07C303/44—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Istotą rozwiązania według wynalazku są nowe związki potencjalnie aktywnie farmaceutycznie z grupy NLPZ — kryształy soli potasowej nimesulidu o wzorze sumarycznym C<sub>13</sub>H<sub>11</sub>N<sub>2</sub>O<sub>5</sub>SK — pokazany jako wzór 1 oraz uwodnionej soli potasowej o wzorze sumarycznym C<sub>39</sub>H<sub>50</sub>N<sub>6</sub>O<sub>23</sub>S<sub>3</sub>K<sub>2</sub> — pokazany jako wzór 2. W przedstawionych związkach nimesulid występuje w postaci zjonizowanej — anionu — a funkcje przeciwojonu pełni jon potasowy K<sup>+</sup>, co łączy wynalazki. Struktury związków różnią się tylko liczbą jonów potasu i nimesulidu oraz brakiem albo obecnością cząsteczek wody. Wynalazek to również sposób otrzymywania.
PL444224A 2023-03-28 2023-03-28 Sól potasowa nimesulidu oraz sposób otrzymywania kryształów soli potasowych nimesulidu PL249273B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL444224A PL249273B1 (pl) 2023-03-28 2023-03-28 Sól potasowa nimesulidu oraz sposób otrzymywania kryształów soli potasowych nimesulidu
EP23169129.6A EP4438593A1 (en) 2023-03-28 2023-04-21 Potassium salt of nimesulide and method for obtaining potassium salt crystals of nimesulide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL444224A PL249273B1 (pl) 2023-03-28 2023-03-28 Sól potasowa nimesulidu oraz sposób otrzymywania kryształów soli potasowych nimesulidu

Publications (2)

Publication Number Publication Date
PL444224A1 true PL444224A1 (pl) 2024-09-30
PL249273B1 PL249273B1 (pl) 2026-03-16

Family

ID=86692754

Family Applications (1)

Application Number Title Priority Date Filing Date
PL444224A PL249273B1 (pl) 2023-03-28 2023-03-28 Sól potasowa nimesulidu oraz sposób otrzymywania kryształów soli potasowych nimesulidu

Country Status (2)

Country Link
EP (1) EP4438593A1 (pl)
PL (1) PL249273B1 (pl)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0869117A1 (en) * 1997-04-01 1998-10-07 Dompe' International S.A.M. Nimesulide choline salt, a process for the preparation thereof and pharmaceutical compositions containing it
EP0937709A1 (en) * 1998-02-10 1999-08-25 Helsinn Healthcare S.A. Nimesulide micronised salts
EP1604976A1 (en) * 2004-06-03 2005-12-14 Advance Holdings Limited Nimesulide derivative method for its preparation and a pharmaceutical composition containing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840597A (en) * 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
PL115076B1 (en) 1977-12-10 1981-03-31 Kopalnia Wegla Kamiennego Ryme Cradle return mechanism in particular for cradle cars used in mines
HU210922B (en) * 1993-05-24 1995-09-28 Europharmaceuticals Sa Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
IT1289973B1 (it) 1997-02-25 1998-10-19 Helsinn Healthcare Sa Sistemi gelificati di nimesulide per uso topico

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0869117A1 (en) * 1997-04-01 1998-10-07 Dompe' International S.A.M. Nimesulide choline salt, a process for the preparation thereof and pharmaceutical compositions containing it
EP0937709A1 (en) * 1998-02-10 1999-08-25 Helsinn Healthcare S.A. Nimesulide micronised salts
EP1604976A1 (en) * 2004-06-03 2005-12-14 Advance Holdings Limited Nimesulide derivative method for its preparation and a pharmaceutical composition containing the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GOOGLE; Agnieszka Sokal, Edyta Pindelska, KOKRYSZTAŁY – NOWA FORMA LEKU - Biul. Wydz. Farm. WUM, 2013, 5, 37-41 http://biuletynfarmacji.wum.edu.pl/ *
GOOGLE; Piera Di Martino et al. Characterization and compaction behaviour of nimesulide crystal forms; International Journal of Pharmaceutics; Volume 342, Issues 1–2, 5 September 2007, Pages 137-144 DOI: 10.1016/j.ijpharm.2007.05.009 *

Also Published As

Publication number Publication date
EP4438593A1 (en) 2024-10-02
PL249273B1 (pl) 2026-03-16

Similar Documents

Publication Publication Date Title
CY1126110T1 (el) Παραγωγα βενζοϋδροξαμικου οξεος ως εκλεκτικοι αναστολε1σ του hdac6
EA202092086A1 (ru) Ингибиторы аргиназы
BR112022002605A2 (pt) Formas cristalinas de moduladores de cftr
CY1123821T1 (el) Συνθεσεις και μεθοδοι για τη θεραπεια της δυσλειτουργιας του μεϊβομιανου αδενα
CR20200518A (es) Piridozinonas como inhibidores de parp7
CY1124737T1 (el) Ανταγωνιστες lpa
CO2021004789A2 (es) Piridazinonas y sus métodos de uso
EA202192783A1 (ru) Модулятор регулятора трансмембранной проводимости при муковисцидозе, фармацевтические композиции, способы лечения и способ получения указанного модулятора
CR20200452A (es) Compuestos de aminoacidos y métodos de uso
BR112021017772A2 (pt) Bloqueadores de canais de íons carregados e métodos para uso
BR112018014238A2 (pt) composição e métodos para criopreservação de hutc
CY1112498T1 (el) Φαρμακοτεχνικες μορφες αναστολεων ηdαc
BR112022008575A2 (pt) Bloqueadores de canal iônico carregado e métodos para uso
MX380159B (es) Metodo para tratar una afeccion cutanea y composiciones de este.
EA201890494A1 (ru) Способы лечения вирусных инфекций arenaviridae и coronaviridae
EA201792214A1 (ru) Соединения замещенного хиназолина
EA201890086A1 (ru) 1,4-замещенные производные пиперидина
CY1125169T1 (el) ΕΝΩΣΕΙΣ ΑΜΙΝΟΠΥΡΑΖΙΝΟ ΔΙΟΛΗΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΡΙ3Κ-γ
JOP20230035A1 (ar) مثبطات apol1 وطرق استخدامها
EA201991700A1 (ru) Селективные ингибиторы jak1
MX386616B (es) Compuestos de carfilzomib pegilados.
EA201891313A1 (ru) Замещенные гидроксиалкиламинами и гидроксициклоалкиламинами соединения диаминарилсульфонамидов с избирательной активностью в потенциалзависимых натриевых каналах
MX2018014524A (es) Desinfectante para manos.
CY1116168T1 (el) Συγκρυσταλλοι και αλατα αναστολεων toy ccr3
CL2024001397A1 (es) Inhibidores de molécula pequeña de proteasa 1 específica de ubiquitina (usp1) y usos de los mismos